Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -126,566 | -90,493 | -59,269 | -28,062 | -136,673 |
| Depreciation Amortization | 8,492 | 6,207 | 4,230 | 2,111 | 9,154 |
| Accounts payable and accrued liabilities | -1,469 | -1,946 | -1,189 | 689 | -2,361 |
| Other Working Capital | -8,408 | -11,108 | -8,333 | -9,046 | 9,380 |
| Other Operating Activity | 17,816 | 11,428 | 6,981 | 4,060 | 32,152 |
| Operating Cash Flow | $-110,135 | $-85,912 | $-57,580 | $-30,248 | $-88,348 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 57,244 | 26,463 | -11,911 | 12,080 | 74,868 |
| PPE Investments | -154 | 21 | -804 | -539 | -13,736 |
| Net Acquisitions | -9,608 | -9,608 | -9,608 | N/A | N/A |
| Investing Cash Flow | $47,482 | $16,876 | $-22,323 | $11,541 | $61,132 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -10,241 |
| Common Stock Issued | 141 | 743 | 470 | 366 | 516 |
| Other Financing Activity | 74,422 | 74,422 | 74,422 | 17,829 | 0 |
| Financing Cash Flow | $74,563 | $75,165 | $74,892 | $18,195 | $-9,725 |
| Beginning Cash Position | 49,303 | 49,303 | 49,303 | 49,303 | 86,244 |
| End Cash Position | 61,213 | 55,432 | 44,292 | 48,791 | 49,303 |
| Net Cash Flow | $11,910 | $6,129 | $-5,011 | $-512 | $-36,941 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,135 | -85,912 | -57,580 | -30,248 | -88,348 |
| Capital Expenditure | -154 | 21 | -804 | -539 | -13,736 |
| Free Cash Flow | -110,289 | -85,891 | -58,384 | -30,787 | -102,084 |